Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China flag China · Delayed Price · Currency is CNY
8.18
-0.34 (-3.99%)
At close: Sep 11, 2026

SHE:301301 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
591.66769.011,400940.56411.52111.35
Depreciation & Amortization
597.77587.5558.47550.11547.73524.05
Other Amortization
0.880.880.880.991.320.66
Loss (Gain) From Sale of Assets
0.01-0.35--1.34--0.26
Asset Writedown & Restructuring Costs
1.251.391.251.2831.5516.82
Loss (Gain) From Sale of Investments
5.463.55-0.364.573.7-3.89
Provision & Write-off of Bad Debts
-0.713.69-6.696.5--
Other Operating Activities
50.5863.8672.44127.13138.23167.77
Change in Accounts Receivable
-18.04-527.48-557.51-274.69-424.1978.13
Change in Inventory
-311.53-182.29317.3-335.4653.31-7.75
Change in Accounts Payable
19.28-162.49-7.99264.92-63.77-80.07
Change in Other Net Operating Assets
-7.3-7.312.4917.9-3.46-0.66
Operating Cash Flow
932.93549.061,7911,292691.64803.21
Operating Cash Flow Growth
-33.84%-69.34%38.59%86.86%-13.89%23.61%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-102.9-97.21-42.6-345.13-47.2-52.27
Sale of Property, Plant & Equipment
000.050.02-0.77
Investment in Securities
-335.01-134.72-64.29--73.34
Other Investing Activities
-1.02-0.63-8.27--
Investing Cash Flow
-438.93-231.93-106.22-353.37-54.2-48.16

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-747.99780851.81,164932.93
Long-Term Debt Repaid
--818.94-1,622-2,369-1,582-1,514
Lease Payments
-33.48-1.6-60.86-11.94-2.43-0.43
Net Debt Issued (Repaid)
-35.51-70.95-842.19-1,517-417.97-581.5
Issuance of Common Stock
8.7912.9420.26-1,050-
Common Dividends Paid
-404.1-622.1-545.07-290.12-142.82-167.8
Other Financing Activities
6.26.25.93-1.07-13.42-
Financing Cash Flow
-424.62-673.92-1,361-1,808475.92-749.29

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-5.112.676.543.334.1-6.51
Net Cash Flow
64.27-354.12330.32-866.111,117-0.76

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
830.03451.851,748947.26644.44750.94
Free Cash Flow Growth
-39.81%-74.16%84.58%46.99%-14.18%33.96%
Free Cash Flow Margin
19.01%9.79%30.36%19.64%16.87%23.23%
Free Cash Flow Per Share
0.360.200.790.420.330.41
Levered Free Cash Flow
813.01367.981,681855.08538.48712.11
Unlevered Free Cash Flow
832.22389.111,719909.94627.44822.66
Free Cash Flow After Leases
796.54450.241,688935.32642750.52

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
316.84517.11648.47529.02283.66134.55
Change in Working Capital
-313.96-880.47-235.25-337.42-442.41-13.29